Concept Richtlijn Erfelijke darmkanker 2007 versie 7 - Oncoline

16. Ponz de Leon M, Benatti P, Di Gregorio C, Pedroni M, Losi L, Genuardi M et al. Genetictesting among high-risk individuals in families with hereditary nonpolyposis colorectalcancer. Br J Cancer 2004;90:882-7.17. Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T. Adherence to screeningexaminations for colorectal cancer after diagnosis in a first-degree relative. Prev Med1995;24:166-70.18. Stanley AJ, gaff CL, Aittomaki AK, Fabre LC, Macrae FA, StJohn J. Value of predictivegenetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC).Med J Aust. 2000;172:313-6.19. Stephenson BM, Murday VA, Finan PJ, Quirke P, Dixon MF, Bishop DT. Feasibility offamily based screening for colorectal neoplasia: experience in one general surgicalpractice. Gut 1993;34:96-100.20. Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH et al.Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50families. Eur J Cancer 1995;31A:1145-8.21. Wagner A, van Kessel I, Kriege MG, Tops CM, Wijnen JT, Vasen HF et al. Long termfollow-up of HNPCC gene mutation carriers: compliance with screening and satisfactionwith counseling and screening procedures. Fam Cancer 2005;4:295-300.Concept landelijke richtlijn erfelijke darmkanker versie 7 d.d. 7 november 2007.73